To understand how Tasigna works, and why Tasigna lawsuit filings are growing, you need to understand a little about a type of cancer called Philadelphia chronic myeloid leukemia. This type of cancer forms in the marrow of your bones and causes an overabundance of white blood cells which spill into the blood and travel and settle elsewhere in the body. Tasigna was approved by the FDA as a treatment for Ph+CML. It works by blocking the proteins cancer cells need to activate and spread without harming non-cancerous cells.
Unfortunately, some patients who are treated with Tasigna are developing of fast-progressing, irreversible form of atherosclerosis, a dangerous condition that may result in heart attack, stroke, gangrene, amputations, and death.
What is Atherosclerosis?
Atherosclerosis is a dangerous condition that causes the arteries to become thick and stiff with plaque build-up. This buildup can narrow the artery, reducing the amount of blood that is fed to critical organs. Atherosclerosis can cause the blood flow to the heart to be reduced, and it can restrict blood flow to the brain and blood flow to the upper and lower extremities.
Atherosclerosis can cause peripheral artery disease, coronary artery disease, and carotid artery disease. These conditions can result in the patient suffering:
- Blocked arteries
- Arm or leg amputations
- Heart attack
- Severe infections
- Serious cardiovascular issues
- Tissue death and gangrene
What Can Be Done About It
Any patient who developed hardened arteries after being treated with Tasigna may be entitled to seek justice for the injuries they have sustained and the losses they have incurred. In fact, lawsuits are already being filed across the country on behalf of patients harmed by Tasigna and on behalf of families whose loved ones died from complications of atherosclerosis.
The lawsuits are questioning why Tasigna maker Novartis did not warn patients and their physicians about the risks of atherosclerosis and its dangerous and potentially life-threatening side effects, especially when the company did warn the Canadian medical community through alerts, patient information brochures, physician reference documents, the Health Canada website and the Novartis Canada website.
Patients in the United States what to know why they were denied the information that would have allowed them to make informed treatment decisions including whether the increased risks of atherosclerosis and its resulting complications are worth the potential benefits of the drug. They want to know when the company knew about those risks and how long they hid them.
If you or a family member was treated with Tasigna and developed fast-progressing, irreversible hardening of the arteries, you may be eligible to seek justice and hold Novartis liable for the injuries you have suffered and the losses you have incurred.
Patients who want answers from the pharmaceutical giant Novartis should speak with a highly experienced and skilled attorney first. They will have the resources and tools needed to take on big pharma successfully. An experienced dangerous drug lawyer will ensure your rights are protected and that the playing field is equal in the eyes of the law.